With the rapid implementation of ‘targeted’ therapies, kidney cancer has entered a new era where old paradigms are being challenged, and new ones can be explored. The idea of deliv[...]
 Evaluation of axitinib to downstage cT2a renal tumours and allow partial nephrectomy: a phase II study Abstract Objective To evaluate the ability of neoadjuvant axitinib to redu[...]
Every month, the Editor-in-Chief selects an Article of the Month from the current issue of BJUI. The abstract is reproduced below and you can click on the button to read the full a[...]
The burden of cancer in low‐ and middle‐income countries (LMICs) continues to rise [1]. Evaluation of geographical differences in cancer mortality statistics is specifically of int[...]
This week's editorial comment is from Alexander Cole and discusses: Are historical studies relevant in the setting of grade migration?[...]
Wong et al. [1] evaluate 19 clinical variables (training data) and three supervised machine‐learning algorithms to predict early biochemical recurrence after robot‐assisted prostat[...]